Morphine Sulfate
Brand name: Morphine Sulfate Er
Rank #326 of 500 drugs by total cost
$33.2M
Total Cost
1,023,056
Total Claims
$33.2M
Total Cost
23,238
Prescribers
$32
Cost per Claim
139,418
Beneficiaries
1,024,970
30-Day Fills
$1,431
Avg Cost/Provider
44
Avg Claims/Provider
About Morphine Sulfate
Morphine Sulfate (sold as Morphine Sulfate Er) was prescribed 1,023,056 times by 23,238 Medicare Part D providers in 2023, costing the program $33.2M. At $32 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
| 324 | Tapentadol Hcl (Nucynta) | $33.6M | 29,886 |
| 325 | Dorzolamide Hcl/Timolol Maleat (Dorzolamide-Timolol) | $33.5M | 1,096,480 |
| 326 | Morphine Sulfate (Morphine Sulfate Er) | $33.2M | 1,023,056 |
| 327 | Budesonide (Budesonide Dr) | $33.1M | 120,202 |
| 328 | Mavacamten (Camzyos) | $32.8M | 3,969 |
| 329 | Empagliflozin/Linagliptin (Glyxambi) | $32.6M | 34,331 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology